nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Dacarbazine—sarcoma	0.0966	0.567	CbGbCtD
Betaxolol—CYP1A2—Etoposide—sarcoma	0.0473	0.277	CbGbCtD
Betaxolol—CYP2D6—Doxorubicin—sarcoma	0.0266	0.156	CbGbCtD
Betaxolol—Asthenia—Dactinomycin—sarcoma	0.000989	0.00119	CcSEcCtD
Betaxolol—Feeling abnormal—Mitoxantrone—sarcoma	0.000989	0.00119	CcSEcCtD
Betaxolol—Asthma—Epirubicin—sarcoma	0.000984	0.00119	CcSEcCtD
Betaxolol—Influenza—Epirubicin—sarcoma	0.000984	0.00119	CcSEcCtD
Betaxolol—Dysphagia—Epirubicin—sarcoma	0.000984	0.00119	CcSEcCtD
Betaxolol—Pruritus—Thiotepa—sarcoma	0.000983	0.00118	CcSEcCtD
Betaxolol—Thrombocytopenia—Etoposide—sarcoma	0.000977	0.00118	CcSEcCtD
Betaxolol—Tachycardia—Etoposide—sarcoma	0.000974	0.00117	CcSEcCtD
Betaxolol—Body temperature increased—Vincristine—sarcoma	0.000974	0.00117	CcSEcCtD
Betaxolol—Skin disorder—Etoposide—sarcoma	0.000969	0.00117	CcSEcCtD
Betaxolol—Hyperhidrosis—Etoposide—sarcoma	0.000965	0.00116	CcSEcCtD
Betaxolol—Hypokalaemia—Doxorubicin—sarcoma	0.000958	0.00116	CcSEcCtD
Betaxolol—Angina pectoris—Epirubicin—sarcoma	0.000958	0.00116	CcSEcCtD
Betaxolol—Urticaria—Mitoxantrone—sarcoma	0.000953	0.00115	CcSEcCtD
Betaxolol—Breast disorder—Doxorubicin—sarcoma	0.000952	0.00115	CcSEcCtD
Betaxolol—Anorexia—Etoposide—sarcoma	0.000951	0.00115	CcSEcCtD
Betaxolol—Diarrhoea—Thiotepa—sarcoma	0.000951	0.00115	CcSEcCtD
Betaxolol—Body temperature increased—Mitoxantrone—sarcoma	0.000948	0.00114	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000948	0.00114	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000948	0.00114	CcSEcCtD
Betaxolol—Bronchitis—Epirubicin—sarcoma	0.000946	0.00114	CcSEcCtD
Betaxolol—Diarrhoea—Dactinomycin—sarcoma	0.000943	0.00114	CcSEcCtD
Betaxolol—Nasopharyngitis—Doxorubicin—sarcoma	0.000942	0.00114	CcSEcCtD
Betaxolol—Hypotension—Etoposide—sarcoma	0.000933	0.00112	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000929	0.00112	CcSEcCtD
Betaxolol—Dysuria—Epirubicin—sarcoma	0.00092	0.00111	CcSEcCtD
Betaxolol—Dizziness—Thiotepa—sarcoma	0.000919	0.00111	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Epirubicin—sarcoma	0.000914	0.0011	CcSEcCtD
Betaxolol—Asthma—Doxorubicin—sarcoma	0.00091	0.0011	CcSEcCtD
Betaxolol—Influenza—Doxorubicin—sarcoma	0.00091	0.0011	CcSEcCtD
Betaxolol—Dysphagia—Doxorubicin—sarcoma	0.00091	0.0011	CcSEcCtD
Betaxolol—Hypersensitivity—Vincristine—sarcoma	0.000908	0.00109	CcSEcCtD
Betaxolol—Paraesthesia—Etoposide—sarcoma	0.000896	0.00108	CcSEcCtD
Betaxolol—Weight increased—Epirubicin—sarcoma	0.000895	0.00108	CcSEcCtD
Betaxolol—Weight decreased—Epirubicin—sarcoma	0.00089	0.00107	CcSEcCtD
Betaxolol—Dyspnoea—Etoposide—sarcoma	0.00089	0.00107	CcSEcCtD
Betaxolol—Hyperglycaemia—Epirubicin—sarcoma	0.000887	0.00107	CcSEcCtD
Betaxolol—Angina pectoris—Doxorubicin—sarcoma	0.000887	0.00107	CcSEcCtD
Betaxolol—Hypersensitivity—Mitoxantrone—sarcoma	0.000884	0.00107	CcSEcCtD
Betaxolol—Asthenia—Vincristine—sarcoma	0.000884	0.00107	CcSEcCtD
Betaxolol—Vomiting—Thiotepa—sarcoma	0.000883	0.00106	CcSEcCtD
Betaxolol—Pneumonia—Epirubicin—sarcoma	0.000882	0.00106	CcSEcCtD
Betaxolol—Infestation—Epirubicin—sarcoma	0.000877	0.00106	CcSEcCtD
Betaxolol—Infestation NOS—Epirubicin—sarcoma	0.000877	0.00106	CcSEcCtD
Betaxolol—Vomiting—Dactinomycin—sarcoma	0.000877	0.00106	CcSEcCtD
Betaxolol—Rash—Thiotepa—sarcoma	0.000876	0.00106	CcSEcCtD
Betaxolol—Bronchitis—Doxorubicin—sarcoma	0.000875	0.00106	CcSEcCtD
Betaxolol—Dermatitis—Thiotepa—sarcoma	0.000875	0.00106	CcSEcCtD
Betaxolol—Headache—Thiotepa—sarcoma	0.00087	0.00105	CcSEcCtD
Betaxolol—Rash—Dactinomycin—sarcoma	0.000869	0.00105	CcSEcCtD
Betaxolol—Decreased appetite—Etoposide—sarcoma	0.000868	0.00105	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Etoposide—sarcoma	0.000862	0.00104	CcSEcCtD
Betaxolol—Asthenia—Mitoxantrone—sarcoma	0.000861	0.00104	CcSEcCtD
Betaxolol—Fatigue—Etoposide—sarcoma	0.00086	0.00104	CcSEcCtD
Betaxolol—Neuropathy peripheral—Epirubicin—sarcoma	0.00086	0.00104	CcSEcCtD
Betaxolol—Stomatitis—Epirubicin—sarcoma	0.000855	0.00103	CcSEcCtD
Betaxolol—Pain—Etoposide—sarcoma	0.000853	0.00103	CcSEcCtD
Betaxolol—Constipation—Etoposide—sarcoma	0.000853	0.00103	CcSEcCtD
Betaxolol—Conjunctivitis—Epirubicin—sarcoma	0.000853	0.00103	CcSEcCtD
Betaxolol—Dysuria—Doxorubicin—sarcoma	0.000851	0.00103	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000846	0.00102	CcSEcCtD
Betaxolol—Diarrhoea—Vincristine—sarcoma	0.000843	0.00102	CcSEcCtD
Betaxolol—Sweating—Epirubicin—sarcoma	0.000841	0.00101	CcSEcCtD
Betaxolol—Weight increased—Doxorubicin—sarcoma	0.000828	0.000999	CcSEcCtD
Betaxolol—Epistaxis—Epirubicin—sarcoma	0.000827	0.000997	CcSEcCtD
Betaxolol—Nausea—Thiotepa—sarcoma	0.000825	0.000995	CcSEcCtD
Betaxolol—Weight decreased—Doxorubicin—sarcoma	0.000824	0.000993	CcSEcCtD
Betaxolol—Sinusitis—Epirubicin—sarcoma	0.000823	0.000992	CcSEcCtD
Betaxolol—Feeling abnormal—Etoposide—sarcoma	0.000822	0.000991	CcSEcCtD
Betaxolol—Hyperglycaemia—Doxorubicin—sarcoma	0.000821	0.00099	CcSEcCtD
Betaxolol—Diarrhoea—Mitoxantrone—sarcoma	0.000821	0.00099	CcSEcCtD
Betaxolol—Nausea—Dactinomycin—sarcoma	0.000819	0.000987	CcSEcCtD
Betaxolol—Agranulocytosis—Epirubicin—sarcoma	0.000819	0.000987	CcSEcCtD
Betaxolol—Pneumonia—Doxorubicin—sarcoma	0.000816	0.000984	CcSEcCtD
Betaxolol—Dizziness—Vincristine—sarcoma	0.000815	0.000982	CcSEcCtD
Betaxolol—Infestation NOS—Doxorubicin—sarcoma	0.000812	0.000978	CcSEcCtD
Betaxolol—Infestation—Doxorubicin—sarcoma	0.000812	0.000978	CcSEcCtD
Betaxolol—Bradycardia—Epirubicin—sarcoma	0.000802	0.000966	CcSEcCtD
Betaxolol—Neuropathy peripheral—Doxorubicin—sarcoma	0.000796	0.000959	CcSEcCtD
Betaxolol—Urticaria—Etoposide—sarcoma	0.000793	0.000956	CcSEcCtD
Betaxolol—Stomatitis—Doxorubicin—sarcoma	0.000791	0.000954	CcSEcCtD
Betaxolol—Rhinitis—Epirubicin—sarcoma	0.000789	0.000952	CcSEcCtD
Betaxolol—Body temperature increased—Etoposide—sarcoma	0.000789	0.000951	CcSEcCtD
Betaxolol—Conjunctivitis—Doxorubicin—sarcoma	0.000789	0.000951	CcSEcCtD
Betaxolol—Hypoaesthesia—Epirubicin—sarcoma	0.000783	0.000944	CcSEcCtD
Betaxolol—Vomiting—Vincristine—sarcoma	0.000783	0.000944	CcSEcCtD
Betaxolol—Pharyngitis—Epirubicin—sarcoma	0.000782	0.000942	CcSEcCtD
Betaxolol—Sweating—Doxorubicin—sarcoma	0.000778	0.000938	CcSEcCtD
Betaxolol—Rash—Vincristine—sarcoma	0.000777	0.000936	CcSEcCtD
Betaxolol—Dermatitis—Vincristine—sarcoma	0.000776	0.000936	CcSEcCtD
Betaxolol—Headache—Vincristine—sarcoma	0.000772	0.00093	CcSEcCtD
Betaxolol—Epistaxis—Doxorubicin—sarcoma	0.000766	0.000923	CcSEcCtD
Betaxolol—Vomiting—Mitoxantrone—sarcoma	0.000763	0.00092	CcSEcCtD
Betaxolol—Sinusitis—Doxorubicin—sarcoma	0.000761	0.000918	CcSEcCtD
Betaxolol—Visual impairment—Epirubicin—sarcoma	0.000759	0.000915	CcSEcCtD
Betaxolol—Agranulocytosis—Doxorubicin—sarcoma	0.000757	0.000913	CcSEcCtD
Betaxolol—Rash—Mitoxantrone—sarcoma	0.000757	0.000912	CcSEcCtD
Betaxolol—Dermatitis—Mitoxantrone—sarcoma	0.000756	0.000911	CcSEcCtD
Betaxolol—Headache—Mitoxantrone—sarcoma	0.000752	0.000906	CcSEcCtD
Betaxolol—Bradycardia—Doxorubicin—sarcoma	0.000742	0.000894	CcSEcCtD
Betaxolol—Eye disorder—Epirubicin—sarcoma	0.000736	0.000887	CcSEcCtD
Betaxolol—Hypersensitivity—Etoposide—sarcoma	0.000735	0.000886	CcSEcCtD
Betaxolol—Tinnitus—Epirubicin—sarcoma	0.000734	0.000885	CcSEcCtD
Betaxolol—Nausea—Vincristine—sarcoma	0.000732	0.000882	CcSEcCtD
Betaxolol—Cardiac disorder—Epirubicin—sarcoma	0.000731	0.000881	CcSEcCtD
Betaxolol—Flushing—Epirubicin—sarcoma	0.000731	0.000881	CcSEcCtD
Betaxolol—Rhinitis—Doxorubicin—sarcoma	0.00073	0.00088	CcSEcCtD
Betaxolol—Hypoaesthesia—Doxorubicin—sarcoma	0.000725	0.000874	CcSEcCtD
Betaxolol—Pharyngitis—Doxorubicin—sarcoma	0.000723	0.000872	CcSEcCtD
Betaxolol—Asthenia—Etoposide—sarcoma	0.000716	0.000863	CcSEcCtD
Betaxolol—Angiopathy—Epirubicin—sarcoma	0.000714	0.000861	CcSEcCtD
Betaxolol—Nausea—Mitoxantrone—sarcoma	0.000713	0.000859	CcSEcCtD
Betaxolol—Immune system disorder—Epirubicin—sarcoma	0.000711	0.000857	CcSEcCtD
Betaxolol—Mediastinal disorder—Epirubicin—sarcoma	0.00071	0.000855	CcSEcCtD
Betaxolol—Chills—Epirubicin—sarcoma	0.000707	0.000852	CcSEcCtD
Betaxolol—Pruritus—Etoposide—sarcoma	0.000706	0.000851	CcSEcCtD
Betaxolol—Arrhythmia—Epirubicin—sarcoma	0.000703	0.000848	CcSEcCtD
Betaxolol—Visual impairment—Doxorubicin—sarcoma	0.000702	0.000846	CcSEcCtD
Betaxolol—Alopecia—Epirubicin—sarcoma	0.000696	0.000839	CcSEcCtD
Betaxolol—Mental disorder—Epirubicin—sarcoma	0.00069	0.000832	CcSEcCtD
Betaxolol—Malnutrition—Epirubicin—sarcoma	0.000685	0.000826	CcSEcCtD
Betaxolol—Erythema—Epirubicin—sarcoma	0.000685	0.000826	CcSEcCtD
Betaxolol—Diarrhoea—Etoposide—sarcoma	0.000683	0.000823	CcSEcCtD
Betaxolol—Eye disorder—Doxorubicin—sarcoma	0.000681	0.000821	CcSEcCtD
Betaxolol—Tinnitus—Doxorubicin—sarcoma	0.000679	0.000819	CcSEcCtD
Betaxolol—Cardiac disorder—Doxorubicin—sarcoma	0.000676	0.000815	CcSEcCtD
Betaxolol—Flushing—Doxorubicin—sarcoma	0.000676	0.000815	CcSEcCtD
Betaxolol—Tension—Epirubicin—sarcoma	0.000673	0.000811	CcSEcCtD
Betaxolol—Dysgeusia—Epirubicin—sarcoma	0.000671	0.000809	CcSEcCtD
Betaxolol—Nervousness—Epirubicin—sarcoma	0.000666	0.000803	CcSEcCtD
Betaxolol—Angiopathy—Doxorubicin—sarcoma	0.000661	0.000797	CcSEcCtD
Betaxolol—Dizziness—Etoposide—sarcoma	0.00066	0.000796	CcSEcCtD
Betaxolol—Muscle spasms—Epirubicin—sarcoma	0.000659	0.000794	CcSEcCtD
Betaxolol—Immune system disorder—Doxorubicin—sarcoma	0.000658	0.000793	CcSEcCtD
Betaxolol—Mediastinal disorder—Doxorubicin—sarcoma	0.000657	0.000792	CcSEcCtD
Betaxolol—Chills—Doxorubicin—sarcoma	0.000654	0.000788	CcSEcCtD
Betaxolol—Arrhythmia—Doxorubicin—sarcoma	0.000651	0.000785	CcSEcCtD
Betaxolol—Vision blurred—Epirubicin—sarcoma	0.000646	0.000779	CcSEcCtD
Betaxolol—Alopecia—Doxorubicin—sarcoma	0.000644	0.000776	CcSEcCtD
Betaxolol—Mental disorder—Doxorubicin—sarcoma	0.000638	0.000769	CcSEcCtD
Betaxolol—Ill-defined disorder—Epirubicin—sarcoma	0.000636	0.000767	CcSEcCtD
Betaxolol—Vomiting—Etoposide—sarcoma	0.000635	0.000765	CcSEcCtD
Betaxolol—Malnutrition—Doxorubicin—sarcoma	0.000634	0.000765	CcSEcCtD
Betaxolol—Erythema—Doxorubicin—sarcoma	0.000634	0.000765	CcSEcCtD
Betaxolol—Anaemia—Epirubicin—sarcoma	0.000634	0.000764	CcSEcCtD
Betaxolol—Rash—Etoposide—sarcoma	0.000629	0.000759	CcSEcCtD
Betaxolol—Dermatitis—Etoposide—sarcoma	0.000629	0.000758	CcSEcCtD
Betaxolol—Headache—Etoposide—sarcoma	0.000625	0.000754	CcSEcCtD
Betaxolol—Tension—Doxorubicin—sarcoma	0.000622	0.00075	CcSEcCtD
Betaxolol—Dysgeusia—Doxorubicin—sarcoma	0.000621	0.000749	CcSEcCtD
Betaxolol—Malaise—Epirubicin—sarcoma	0.000618	0.000745	CcSEcCtD
Betaxolol—Nervousness—Doxorubicin—sarcoma	0.000616	0.000743	CcSEcCtD
Betaxolol—Vertigo—Epirubicin—sarcoma	0.000616	0.000742	CcSEcCtD
Betaxolol—Syncope—Epirubicin—sarcoma	0.000615	0.000741	CcSEcCtD
Betaxolol—Muscle spasms—Doxorubicin—sarcoma	0.00061	0.000735	CcSEcCtD
Betaxolol—Palpitations—Epirubicin—sarcoma	0.000606	0.00073	CcSEcCtD
Betaxolol—Loss of consciousness—Epirubicin—sarcoma	0.000602	0.000726	CcSEcCtD
Betaxolol—Cough—Epirubicin—sarcoma	0.000598	0.000721	CcSEcCtD
Betaxolol—Vision blurred—Doxorubicin—sarcoma	0.000598	0.000721	CcSEcCtD
Betaxolol—Nausea—Etoposide—sarcoma	0.000593	0.000715	CcSEcCtD
Betaxolol—Ill-defined disorder—Doxorubicin—sarcoma	0.000588	0.000709	CcSEcCtD
Betaxolol—Anaemia—Doxorubicin—sarcoma	0.000586	0.000707	CcSEcCtD
Betaxolol—Arthralgia—Epirubicin—sarcoma	0.000584	0.000703	CcSEcCtD
Betaxolol—Myalgia—Epirubicin—sarcoma	0.000584	0.000703	CcSEcCtD
Betaxolol—Chest pain—Epirubicin—sarcoma	0.000584	0.000703	CcSEcCtD
Betaxolol—Anxiety—Epirubicin—sarcoma	0.000582	0.000701	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00058	0.000699	CcSEcCtD
Betaxolol—Discomfort—Epirubicin—sarcoma	0.000577	0.000695	CcSEcCtD
Betaxolol—Malaise—Doxorubicin—sarcoma	0.000572	0.000689	CcSEcCtD
Betaxolol—Dry mouth—Epirubicin—sarcoma	0.000571	0.000688	CcSEcCtD
Betaxolol—Vertigo—Doxorubicin—sarcoma	0.00057	0.000687	CcSEcCtD
Betaxolol—Syncope—Doxorubicin—sarcoma	0.000569	0.000686	CcSEcCtD
Betaxolol—Confusional state—Epirubicin—sarcoma	0.000564	0.00068	CcSEcCtD
Betaxolol—Palpitations—Doxorubicin—sarcoma	0.00056	0.000676	CcSEcCtD
Betaxolol—Oedema—Epirubicin—sarcoma	0.000559	0.000674	CcSEcCtD
Betaxolol—Loss of consciousness—Doxorubicin—sarcoma	0.000557	0.000672	CcSEcCtD
Betaxolol—Infection—Epirubicin—sarcoma	0.000556	0.00067	CcSEcCtD
Betaxolol—Cough—Doxorubicin—sarcoma	0.000553	0.000667	CcSEcCtD
Betaxolol—Shock—Epirubicin—sarcoma	0.00055	0.000663	CcSEcCtD
Betaxolol—Nervous system disorder—Epirubicin—sarcoma	0.000549	0.000661	CcSEcCtD
Betaxolol—Thrombocytopenia—Epirubicin—sarcoma	0.000548	0.00066	CcSEcCtD
Betaxolol—Tachycardia—Epirubicin—sarcoma	0.000546	0.000658	CcSEcCtD
Betaxolol—Skin disorder—Epirubicin—sarcoma	0.000543	0.000655	CcSEcCtD
Betaxolol—Hyperhidrosis—Epirubicin—sarcoma	0.000541	0.000652	CcSEcCtD
Betaxolol—Myalgia—Doxorubicin—sarcoma	0.00054	0.000651	CcSEcCtD
Betaxolol—Arthralgia—Doxorubicin—sarcoma	0.00054	0.000651	CcSEcCtD
Betaxolol—Chest pain—Doxorubicin—sarcoma	0.00054	0.000651	CcSEcCtD
Betaxolol—Anxiety—Doxorubicin—sarcoma	0.000538	0.000649	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000536	0.000646	CcSEcCtD
Betaxolol—Discomfort—Doxorubicin—sarcoma	0.000534	0.000643	CcSEcCtD
Betaxolol—Anorexia—Epirubicin—sarcoma	0.000533	0.000643	CcSEcCtD
Betaxolol—Dry mouth—Doxorubicin—sarcoma	0.000528	0.000637	CcSEcCtD
Betaxolol—Hypotension—Epirubicin—sarcoma	0.000523	0.00063	CcSEcCtD
Betaxolol—Confusional state—Doxorubicin—sarcoma	0.000522	0.000629	CcSEcCtD
Betaxolol—Oedema—Doxorubicin—sarcoma	0.000518	0.000624	CcSEcCtD
Betaxolol—Infection—Doxorubicin—sarcoma	0.000514	0.00062	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00051	0.000614	CcSEcCtD
Betaxolol—Shock—Doxorubicin—sarcoma	0.000509	0.000614	CcSEcCtD
Betaxolol—Nervous system disorder—Doxorubicin—sarcoma	0.000508	0.000612	CcSEcCtD
Betaxolol—Thrombocytopenia—Doxorubicin—sarcoma	0.000507	0.000611	CcSEcCtD
Betaxolol—Insomnia—Epirubicin—sarcoma	0.000506	0.00061	CcSEcCtD
Betaxolol—Tachycardia—Doxorubicin—sarcoma	0.000505	0.000609	CcSEcCtD
Betaxolol—Skin disorder—Doxorubicin—sarcoma	0.000503	0.000606	CcSEcCtD
Betaxolol—Paraesthesia—Epirubicin—sarcoma	0.000502	0.000606	CcSEcCtD
Betaxolol—Hyperhidrosis—Doxorubicin—sarcoma	0.0005	0.000603	CcSEcCtD
Betaxolol—Dyspnoea—Epirubicin—sarcoma	0.000499	0.000601	CcSEcCtD
Betaxolol—Anorexia—Doxorubicin—sarcoma	0.000493	0.000595	CcSEcCtD
Betaxolol—Dyspepsia—Epirubicin—sarcoma	0.000492	0.000594	CcSEcCtD
Betaxolol—Decreased appetite—Epirubicin—sarcoma	0.000486	0.000586	CcSEcCtD
Betaxolol—Hypotension—Doxorubicin—sarcoma	0.000484	0.000583	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000483	0.000582	CcSEcCtD
Betaxolol—Fatigue—Epirubicin—sarcoma	0.000482	0.000581	CcSEcCtD
Betaxolol—Constipation—Epirubicin—sarcoma	0.000478	0.000577	CcSEcCtD
Betaxolol—Pain—Epirubicin—sarcoma	0.000478	0.000577	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000472	0.000568	CcSEcCtD
Betaxolol—Insomnia—Doxorubicin—sarcoma	0.000468	0.000564	CcSEcCtD
Betaxolol—Paraesthesia—Doxorubicin—sarcoma	0.000465	0.00056	CcSEcCtD
Betaxolol—Dyspnoea—Doxorubicin—sarcoma	0.000461	0.000556	CcSEcCtD
Betaxolol—Feeling abnormal—Epirubicin—sarcoma	0.000461	0.000556	CcSEcCtD
Betaxolol—Dyspepsia—Doxorubicin—sarcoma	0.000456	0.000549	CcSEcCtD
Betaxolol—Decreased appetite—Doxorubicin—sarcoma	0.00045	0.000542	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000447	0.000539	CcSEcCtD
Betaxolol—Fatigue—Doxorubicin—sarcoma	0.000446	0.000538	CcSEcCtD
Betaxolol—Urticaria—Epirubicin—sarcoma	0.000444	0.000536	CcSEcCtD
Betaxolol—Pain—Doxorubicin—sarcoma	0.000443	0.000534	CcSEcCtD
Betaxolol—Constipation—Doxorubicin—sarcoma	0.000443	0.000534	CcSEcCtD
Betaxolol—Body temperature increased—Epirubicin—sarcoma	0.000442	0.000533	CcSEcCtD
Betaxolol—Feeling abnormal—Doxorubicin—sarcoma	0.000427	0.000514	CcSEcCtD
Betaxolol—Hypersensitivity—Epirubicin—sarcoma	0.000412	0.000497	CcSEcCtD
Betaxolol—Urticaria—Doxorubicin—sarcoma	0.000411	0.000496	CcSEcCtD
Betaxolol—Body temperature increased—Doxorubicin—sarcoma	0.000409	0.000493	CcSEcCtD
Betaxolol—Asthenia—Epirubicin—sarcoma	0.000401	0.000484	CcSEcCtD
Betaxolol—Pruritus—Epirubicin—sarcoma	0.000396	0.000477	CcSEcCtD
Betaxolol—Diarrhoea—Epirubicin—sarcoma	0.000383	0.000461	CcSEcCtD
Betaxolol—Hypersensitivity—Doxorubicin—sarcoma	0.000381	0.00046	CcSEcCtD
Betaxolol—Asthenia—Doxorubicin—sarcoma	0.000371	0.000448	CcSEcCtD
Betaxolol—Dizziness—Epirubicin—sarcoma	0.00037	0.000446	CcSEcCtD
Betaxolol—Pruritus—Doxorubicin—sarcoma	0.000366	0.000441	CcSEcCtD
Betaxolol—Vomiting—Epirubicin—sarcoma	0.000356	0.000429	CcSEcCtD
Betaxolol—Diarrhoea—Doxorubicin—sarcoma	0.000354	0.000427	CcSEcCtD
Betaxolol—Rash—Epirubicin—sarcoma	0.000353	0.000425	CcSEcCtD
Betaxolol—Dermatitis—Epirubicin—sarcoma	0.000352	0.000425	CcSEcCtD
Betaxolol—Headache—Epirubicin—sarcoma	0.00035	0.000422	CcSEcCtD
Betaxolol—Dizziness—Doxorubicin—sarcoma	0.000342	0.000413	CcSEcCtD
Betaxolol—Nausea—Epirubicin—sarcoma	0.000332	0.000401	CcSEcCtD
Betaxolol—Vomiting—Doxorubicin—sarcoma	0.000329	0.000397	CcSEcCtD
Betaxolol—Rash—Doxorubicin—sarcoma	0.000326	0.000393	CcSEcCtD
Betaxolol—Dermatitis—Doxorubicin—sarcoma	0.000326	0.000393	CcSEcCtD
Betaxolol—Headache—Doxorubicin—sarcoma	0.000324	0.000391	CcSEcCtD
Betaxolol—Nausea—Doxorubicin—sarcoma	0.000307	0.000371	CcSEcCtD
